NCT00703898View on ClinicalTrials.gov

Durability of Nevirapine-Based Antiretroviral Regimen

PHASE4CompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

December 31, 2009

Study Completion Date

April 30, 2010

Conditions
HIV Infections
Interventions
DRUG

nevirapine

200 mg/day twice a day

Trial Locations (1)

11000

Department of Medicine, Bamrasnaradura Infectious Diseases Institute, Nonthaburi

All Listed Sponsors
lead

Bamrasnaradura Infectious Diseases Institute

OTHER_GOV

NCT00703898 - Durability of Nevirapine-Based Antiretroviral Regimen | Biotech Hunter | Biotech Hunter